Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: Involvement of PI3K/AKT and NF-κB pathways

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 16, 2012, Pages 4083-4089

  Ko, Hyun Suk ^a   Lee, Hyo Jeong ^a   Kim, Sung Hoon ^a   Lee, Eun Ok ^a  

^a Kyung Hee University   (South Korea)

Author keywords

invasion; MDA MB 231 cells; MMP 9; PI3K AKT, NF B; piceatannol

Indexed keywords

BREAST CANCER CELLS; CANCER INVASION; CANCER PATIENTS; CELL INVASION; DNA BINDING; INVASION; MAMMALIAN TARGET OF RAPAMYCIN (MTOR); MATRIX METALLOPROTEINASE-9; MMP-9; MRNA LEVEL; NUCLEAR FACTOR KAPPAB; NUCLEAR TRANSLOCATIONS; PHOSPHATASE AND TENSIN HOMOLOGUES; PICEATANNOL; RESVERATROL; TRANS-STILBENE; TRANSCRIPTIONAL ACTIVITY; TREATMENT FAILURE;

ADHESION; ANTIBIOTICS; CYTOLOGY; DISEASES; NUCLEIC ACIDS; PATIENT TREATMENT; PHOSPHORYLATION;

CELLS;

3,3',4,5'-TETRAHYDROXYSTILBENE; ANTINEOPLASTIC AGENT; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PICEATANNOL; PROTEIN KINASE B; STILBENE DERIVATIVE;

ARTICLE; BREAST TUMOR; CELL MOTION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STILBENES;

MAMMALIA;

EID: 84860334952     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf205171g     Document Type: Article

References (40)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics CA Cancer J. Clin. 2008, 61, 69-90
2. Adams, L. S.; Phung, S.; Yee, N.; Seeram, N. P.; Li, L.; Chen, S. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway Cancer Res. 2010, 70, 3594-3605
3. Lee, H. J.; Seo, N. J.; Jeong, S. J.; Park, Y.; Jung, D. B.; Koh, W.; Lee, E. O.; Ahn, K. S.; Lu, J.; Kim, S. H. Oral administration of penta- O -galloyl-β- d -glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition Carcinogenesis 2011, 32, 804-811
4. Liu, P. L.; Tsai, J. R.; Charles, A. L.; Hwang, J. J.; Chou, S. H.; Ping, Y. H.; Lin, F. Y.; Chen, Y. L.; Hung, C. Y.; Chen, W. C.; Chen, Y. H.; Chong, I. W. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-κB pathway and subsequently downregulating expression of matrix metalloproteinases Mol. Nutr. Food Res. 2010, 54, 1-9
5. Christofori, G. New signals from the invasive front Nature 2006, 441, 444-450 (Pubitemid 44050139)
6. Folgueras, A. R.; Pendas, A. M.; Sanchez, L. M.; Lopez-Otin, C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies Int. J. Dev. Biol. 2004, 48, 411-424 (Pubitemid 39360392)
7. Kessenbrock, K.; Plaks, V.; Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment Cell 2010, 141, 52-67
8. Coussens, L. M.; Fingleton, B.; Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 2002, 295, 2387-2392 (Pubitemid 34270240)
9. Stark, A. M.; Anuszkiewicz, B.; Mentlein, R.; Yoneda, T.; Mehdorn, H. M.; Held-Feindt, J. Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells J. Neurooncol. 2007, 81, 39-48 (Pubitemid 44963987)
10. Yoon, H.; Liu, R. H. Effect of selected phytochemicals and apple extracts on NF-κB activation in human breast cancer MCF-7 cells J. Agric. Food Chem. 2007, 55, 3167-3173 (Pubitemid 46671353)
11. Lee, B.; Lee, E. J.; Kim, D. I.; Park, S. K.; Kim, W. J.; Moon, S. K. Inhibition of proliferation and migration by piceatannol in vascular smooth muscle cells Toxicol. In Vitro 2009, 23, 1284-1291
12. Kwon, G. T.; Jung, J. I.; Song, H. R.; Woo, E. Y.; Jun, J. G.; Kim, J. K.; Her, S.; Park, J. H. Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling. J. Nutr. Biochem. 2011, April 14.
13. Choi, K. H.; Kim, J. E.; Song, N. R.; Son, J. E.; Hwang, M. K.; Byun, S.; Kim, J. H.; Lee, K. W.; Lee, H. J. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells Cardiovasc. Res. 2009, 85, 836-844
14. Kim, E. J.; Park, H.; Park, S. Y.; Jun, J. G.; Park, J. H. The grape component piceatannol induces apoptosis in DU145 human prostate cancer cells via the activation of extrinsic and intrinsic pathways J. Med. Food 2009, 12, 943-951
15. Kim, Y. H.; Park, C.; Lee, J. O.; Kim, G. Y.; Lee, W. H.; Choi, Y. H.; Ryu, C. H. Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases Oncol. Rep. 2008, 19, 961-967 (Pubitemid 351802666)
16. Lee, Y. M.; Lim do, Y.; Cho, H. J.; Seon, M. R.; Kim, J. K.; Lee, B. Y.; Park, J. H. Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity Cancer Lett. 2009, 285, 166-173
17. Wolter, F.; Clausnitzer, A.; Akoglu, B.; Stein, J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines J. Nutr. 2002, 132, 298-302 (Pubitemid 34135611)
18. Maggiolini, M.; Recchia, A. G.; Bonofiglio, D.; Catalano, S.; Vivacqua, A.; Carpino, A.; Rago, V.; Rossi, R.; Ando, S. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor α in human breast cancer cells J. Mol. Endocrinol. 2005, 35, 269-281 (Pubitemid 41556175)
19. Kimura, Y.; Baba, K.; Okuda, H. Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (part 2) Anticancer Res. 2000, 20, 2923-2930
20. Choo, E. J.; Rhee, Y. H.; Jeong, S. J.; Lee, H. J.; Kim, H. S.; Ko, H. S.; Kim, J. H.; Kwon, T. R.; Jung, J. H.; Lee, E. O.; Kim, D. K.; Chen, C. Y.; Kim, S. H. Anethole exerts antimetatstaic activity via inhibition of matrix metalloproteinase 2/9 and AKT/mitogen-activated kinase/nuclear factor κB signaling pathways Biol. Pharm. Bull. 2011, 34, 41-46
21. Bourboulia, D.; Stetler-Stevenson, W. G. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion Semin. Cancer Biol. 2010, 20, 161-168
22. Baselga, J. Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer Oncologist 2011, 16 (Suppl. 1) 12-19
23. Chen, J. S.; Wang, Q.; Fu, X. H.; Huang, X. H.; Chen, X. L.; Cao, L. Q.; Chen, L. Z.; Tan, H. X.; Li, W.; Bi, J.; Zhang, L. J. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9 Hepatol. Res. 2009, 39, 177-186
24. Kim, Y.; Kang, H.; Jang, S. W.; Ko, J. Celastrol inhibits breast cancer cell invasion via suppression of NF-κB-mediated matrix metalloproteinase-9 expression Cell. Physiol. Biochem. 2011, 28, 175-184
25. Ling, H.; Yang, H.; Tan, S. H.; Chui, W. K.; Chew, E. H. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation Br. J. Pharmacol. 2010, 161, 1763-1777
26. Karroum, A.; Mirshahi, P.; Benabbou, N.; Faussat, A. M.; Soria, J.; Therwath, A.; Mirshahi, M.; Hatmi, M. Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways Cancer Lett. 2010, 295, 242-251
27. Lee, W. J.; Chen, W. K.; Wang, C. J.; Lin, W. L.; Tseng, T. H. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells Toxicol. Appl. Pharmacol. 2008, 226, 178-191
28. Kousidou, O. C.; Roussidis, A. E.; Theocharis, A. D.; Karamanos, N. K. Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential Anticancer Res. 2004, 24, 4025-4030 (Pubitemid 40468702)
29. Lin, K. L.; Chien, C. M.; Hsieh, C. Y.; Tsai, P. C.; Chang, L. S.; Lin, S. R. Antimetastatic potential of cardiotoxin III involves inactivation of PI3K/Akt and p38 MAPK signaling pathways in human breast cancer MDA-MB-231 cells. Life Sci. 2011, Oct 31.
30. Huang, G. J.; Yang, C. M.; Chang, Y. S.; Amagaya, S.; Wang, H. C.; Hou, W. C.; Huang, S. S.; Hu, M. L. Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways J. Agric. Food Chem. 2010, 58, 9468-9475
31. Testa, J. R.; Bellacosa, A. AKT plays a central role in tumorigenesis Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10983-10985 (Pubitemid 32928669)
32. Busch, S.; Renaud, S. J.; Schleussner, E.; Graham, C. H.; Markert, U. R. mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3 Exp. Cell Res. 2009, 315, 1724-1733
33. Blanco-Aparicio, C.; Renner, O.; Leal, J. F.; Carnero, A. PTEN, more than the AKT pathway Carcinogenesis 2007, 28, 1379-1386 (Pubitemid 47243536)
34. Georgescu, M. M. PTEN tumor suppressor network in PI3K-Akt pathway control Genes Cancer 2011, 1, 1170-1177
35. Stambolic, V.; Suzuki, A.; de la Pompa, J. L.; Brothers, G. M.; Mirtsos, C.; Sasaki, T.; Ruland, J.; Penninger, J. M.; Siderovski, D. P.; Mak, T. W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 1998, 95, 29-39 (Pubitemid 28458022)
36. Aggarwal, B. B. Nuclear factor-κB: the enemy within Cancer Cell 2004, 6, 203-208
37. Lee, C. H.; Jeon, Y. T.; Kim, S. H.; Song, Y. S. NF-κB as a potential molecular target for cancer therapy Biofactors 2007, 29, 19-35 (Pubitemid 46985299)
38. Wu, J. T.; Kral, J. G. The NF-κB/IκB signaling system: a molecular target in breast cancer therapy J. Surg. Res. 2005, 123, 158-169 (Pubitemid 40094658)
39. Liang, J. A.; Wu, S. L.; Lo, H. Y.; Hsiang, C. Y.; Ho, T. Y. Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-κB signaling pathway in human hepatocellular carcinoma cells Mol. Pharmacol. 2009, 75, 151-157
40. Ashikawa, K.; Majumdar, S.; Banerjee, S.; Bharti, A. C.; Shishodia, S.; Aggarwal, B. B. Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation J. Immunol. 2002, 169, 6490-6407